Cynapsus Therapeutics Inc. — Form D/A

Cynapsus Therapeutics Inc. of TORONTO, A6, a company, filed a Form D amendment with the SEC on 2012-03-28. The offering totals $940K, of which $940K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
DAVID HILLDirectorCharlotte, NC
Alan RyleyDirectorTORONTO, A6
Rochelle StenzlerDirectorTORONTO, A6
Alan TorrieDirectorTORONTO, A6
Ilan OrenDirectorMorrisville, NC
Nathan BrysonExecutive OfficerMorristown, NJ
Andrew WilliamsExecutive OfficerHuntington Beach, CA
Julia LevyDirectorAuburn, WA
Anthony GiovinazzoDirectorMississauga, A6
Anthony GiovinazzoExecutive OfficerMississauga, A6
Perry MolinoffDirectorDALLAS, TX
Margaret Nan HutchinsonDirectorToronto, A6
Thierry D BilbaultExecutive OfficerToronto, A6
Tamar D HowsonDirectorToronto, A6
Ronald HoskingDirectorToronto, A6
Rochelle D StenzlerDirectorToronto, A6
Ilan Nan OrenDirectorToronto, A6
Tomer GoldDirectorToronto, A6
Perry Nan MolinoffDirectorToronto, A6
Nan HutchinsonDirectorToronto, A6
Rochelle D C StenzlerDirectorToronto, A6
Alan D C RyleyDirectorToronto, A6
Alan D C TorrieDirectorToronto, A6

Other filings by this issuer (9)

FiledFormOfferingSold
2015-04-14D$16.8M$16.8M
2014-04-21D$42.9M$14.5M
2013-03-27D/A$13.0M$4.1M
2013-03-20D$2.4M
2013-03-15D$11.2M$3.9M
2012-01-09D/A$762K$762K
2011-12-28D/A$555K$555K
2011-11-18D/A$389K$389K
2011-10-13D$222K$222K

More